RisingPennyStocks.com Has Initiated Coverage of Mistral Ventures Inc.
October 28 2011 - 7:30AM
Marketwired
Mistral Ventures, Inc. (PINKSHEETS: MILV) announced today that it
has reached an agreement with the inventor of a cold and flu
medicine which has been in development for many years. Nature's
Bioceuticals a wholly owned subsidiary of Mistral ventures,
develops and acquires the rights to natural medicine formulas that
are geared towards treating specific medical conditions.
RisingPennyStocks.com gives you the "Ultimate Investors Edge."
Traders who receive alerts first -- at the earliest stage of
increasing price and liquidity -- could be positioned to generate
significant profits.
RisingPennyStocks.com and their Early Bird Newsletter Alert
provide in-depth fundamental and technical factors on stocks that
trade in the Micro-Cap and Small Cap markets. To assists traders
make more informed decisions and locate companies positioned to
increase in volume, liquidity and price movement, we focus on
extensively analyzing growth companies in some of the top sectors
within these financial markets.
For more information, please visit
www.risingpennystocks.com/hotstock/
Other active stocks are AER Resources, Inc (PINKSHEETS: AERN)
White Smile Global (OTCQB: WSML) and Converted Organics (OTCQB:
COIN)
Information, opinions and analysis contained herein are based on
sources believed to be reliable, but no representation, expressed
or implied, is made as to its accuracy, completeness or
correctness. The opinions contained herein reflect our current
judgment and are subject to change without notice. We accept no
liability for any losses arising from an investor's reliance on or
use of this report. This report is for information purposes only,
and is neither a solicitation to buy nor an offer to sell
securities. A third party has hired and paid IO NewsWire twelve
hundred and ninety five dollars for the publication and circulation
of this news release. Certain information included herein is
forward-looking within the meaning of the Private Securities
Litigation Reform Act of 1995, including, but not limited to,
statements concerning manufacturing, marketing, growth, and
expansion. Such forward-looking information involves important
risks and uncertainties that could affect actual results and cause
them to differ materially from expectations expressed herein. We
have no ownership of equity, no representation; do no trading of
any kind and send no faxes or emails.
Contact: IO Circuit Email Contact
AER Energy Resources (CE) (USOTC:AERN)
Historical Stock Chart
From Nov 2024 to Dec 2024
AER Energy Resources (CE) (USOTC:AERN)
Historical Stock Chart
From Dec 2023 to Dec 2024